Reverse payments in US Pharma, Vintage prior art, The ever growing prior art base and Utility models IP Think Tank Podcast 9 Feb 2009 (IP Think Tank podcast)

Pallavi
Kharkar

IP Strategist

Santa Barbara, California US

In Santa Barbara there is no off-season, and there’s always a pleasant climate. It would be wonderful to always be in such a place where there is no off-season and such a great atmosphere. I feel that in our firm, it’s similar, there is no off season and the atmosphere is great. There is work and fun and there’s plenty of down time for real quality of life.

photo credit: cyanocorax

Global IP Strategy >Pharma, Biotech
& Chem IP Strategy >IP wars >Strategic Management
of IP >See All >

Podcast RSS

02.09.2009 — GLOBAL IP STRATEGY, PHARMA, BIOTECH & CHEM IP STRATEGY, IP WARS, STRATEGIC MANAGEMENT OF IP

Reverse payments in US Pharma, Vintage prior art, The ever growing prior art base and Utility models IP Think Tank Podcast 9 Feb 2009

Welcome to the IP Think Tank podcast for Monday the 9th of February 2009. In this week’s call, regular panellists Jeremy Philips and Duncan Bucknell are joined by Peter Ollier to discuss:
• Solvay, Senator Kohl’s proposed US Bill and reverse payments in US pharmaceutical litigation;
• Open season on patents;
• The IPKat’s call for Vintage prior art;
• The impact on patent validity of the ever growing body of knowledge and our increasing ability to retrieve and aggregate it;
• Utility model patents, petty patents, innovation patents and protectionism; and
• Jeremy’s proposed new presidential character right.

We hope you enjoy this week’s podcast, and as always, we look forward to your comments and feedback.

download mp3

Reverse payments in US Pharma, Vintage prior art, The ever growing prior art base and Utility models IP Think Tank Podcast 9 Feb 2009

0 Comments

Post a Comment